Lomitapide: A Medication Use Evaluation and a Formulary Perspective
Introduction Lomitapide is approved for lowering low-density lipoprotein cholesterol (LDL-C) in homozygous familial hypercholesterolemia, which is a rare genetic disorder. The evidence regarding its safety and efficacy from a small clinical trial requires further validation for effectiveness and saf...
Shranjeno v:
| Principais autores: | , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Innovative Healthcare Institute
2024-05-01
|
| Serija: | Global Journal on Quality and Safety in Healthcare |
| Teme: | |
| Online dostop: | https://theijpt.org/doi/pdf/10.36401/JQSH-23-32 |
| Oznake: |
Brez oznak, prvi označite!
|